Kiora Pharmaceuticals, Inc. (NASDAQ:KPRX – Get Free Report) saw a significant decrease in short interest in the month of May. As of May 15th, there was short interest totalling 66,500 shares, a decrease of 50.7% from the April 30th total of 135,000 shares. Based on an average daily trading volume, of 215,600 shares, the short-interest […]
Kiora Pharmaceuticals, Inc. , will participate in two upcoming investor conferences that will be available to investors live with the replay available on-demand. On Wednesday May 22, at 3:00 pm.
Kiora Pharmaceuticals Reports First Quarter Results; Update on Pipeline of Drugs Targeting Retinal Disease marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
KPRX Stock Earnings: Kiora Pharmaceuticals Beats EPS for Q1 2024 biztoc.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biztoc.com Daily Mail and Mail on Sunday newspapers.